mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.041 |
0.3 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.008 |
mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.04 |
0.3 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-07 |
mRNA |
triazolothiadiazine |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-07 |
mRNA |
trifluoperazine |
CTRPv2 |
pan-cancer |
AAC |
0.086 |
0.03 |
mRNA |
triptolide |
CTRPv2 |
pan-cancer |
AAC |
0.063 |
0.09 |
mRNA |
tubastatin A |
CTRPv2 |
pan-cancer |
AAC |
0.23 |
8e-06 |
mRNA |
tubastatin A |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
valdecoxib |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0008 |